Large Cap

Nasdaq 100 Breaks 3-Day Losing Streak As Tech Stocks Rebound Ahead Of Earnings Week
Geopolitical Relief Triggers Gold Selloff: Prices Dip Below $2,350 Mark, Mining Stocks Hit Hard
UnitedHealth CEO To Testify Before US House Panel Regarding Cyberattack On Technology Unit
Geopolitical Relief Triggers Gold Selloff: Prices Dip Below $2,350 Mark, Mining Stocks Hit Hard
UnitedHealth CEO To Testify Before US House Panel Regarding Cyberattack On Technology Unit
Eli Lilly Aims To Close Supply-Demand Gap For Zepbound/Mounjaro As It Acquires Manufacturing Facility From Nexus Pharma
Stocks Set To Snap Worst Losing Streak In Nearly 2 Years, Gold Sinks, Bitcoin Reclaims $66,000: What's Driving Markets Monday?

Large Cap Recent News

Truist Financial Reports Mixed Q1 Earnings, Expects Further Decline In Annual Revenues
Truist Financial reports Q1 earnings, beating EPS estimates at $0.90 but misses revenue projections at $4.87 billion. Net interest income declines. Loan and deposit averages drop.
Changing Frugal Eating Habits - How Novo Nordisk/Eli Lilly's Weight Loss Drugs Reshaping Food Spending
Discover how GLP-1 drugs reshape consumer spending in food industries. Novo Nordisk's Wegvoy and Eli Lilly's Zepbound gain traction, altering dining habits.
Drug Distributing Giant Cardinal Health Will Not Renew OptumRx Distribution Pact, Stock Plunges
Discover the latest updates on Cardinal Health's nonrenewal of OptumRx contracts. Explore its fiscal 2024 guidance and long-term targets amidst market shifts. Learn about its strategies to offset contract impact and drive growth.
Tracking Last Week's Top Performers: Are These 7 Large-Cap Stocks In Your Portfolio?
Last week's top performers included United Airlines, Bentley Systems, Progressive Corp and Morgan Stanley.
Let's Spill The Tea: Top Consumer Tech News From Last Week That You Should Know
Google employees arrested for protesting contract with Israel, Elon Musk accepts challenge from Russian space agency, and more.
Nasdaq 100 Notches Worst Day Since Late 2023, Worst Week Since Late 2022 As AI-Driven Chipmakers Tumble: Fed Can Take 'The Rest Of The Year Off'
The Nasdaq 100 index had its worst day since late October 2023, with a 2.1% drop and fourth consecutive week of declines. Tech stocks have been hit hard by mixed earnings, geopolitical risks, and Fed's reluctance for rate cuts.
S&P 500 Nears 6-Day Slide, Nasdaq 100 Faces Worst Week Since Late 2022: What's Driving Markets Friday?
U.S. stocks are experiencing declines this Friday, on track of ending another week of negative performance.
Johnson & Johnson Children's Cough Syrup Contaminated In Some Batches - WHO Poised to Issue Global Alert
WHO alerts the global community about tainted children's cough syrup by Johnson & Johnson. Elevated toxin levels detected in Benylin syrup prompt recalls across Africa. Investigation is underway.
FDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies
Following an investigation announced in November last year, the FDA said on Thursday that it would now require boxed warnings—the highest safety-rel
German Authority Gives Go Ahead To Novo Nordisk's Small Bolt On Acquisition As Danish Firm Seeks To Build Heart Drugs Pipeline
Novo Nordisk's acquisition of Cardior Pharmaceuticals clears regulatory hurdles, advancing cardiovascular treatment development with CDR132L. Learn about the promising phase 2 trials and strategic expansion. Deal expected to close Q2 2024.
Northrop Grumman And Elon Musk's SpaceX Forge Alliance for US Spy Satellite Initiative
Northrop Grumman & SpaceX collaborate on a classified satellite initiative to enhance US surveillance capabilities. High-resolution imagery from low-Earth orbits diversifies intelligence methods, emphasizing distributed responsibility & sensor technology integration.
Stocks Edge Higher As Earnings Provide Support, Tesla Sinks To 15-Month Lows, Bitcoin Rebounds: What's Driving Markets Thursday?
Stocks surged higher on Thursday, with the S&P 500 index aiming to snap a four-day losing streak as investors assess the latest wave of corporate earnings.
96% Of S&P 500 Stocks Show Upside Potential Vs. Street Estimates: Which Offers The Best Opportunity?
480 out of 500 S&P 500 companies are trading below analysts' price targets, indicating potential profit opportunities. April has been bleak for the market, but some undervalued stocks may be worth buying. Top 5 stocks with biggest gap between price and target: CCL, BIO, WBD, CZR, CCO.

Explore Benzinga's Financial Tools

Find Stocks Tailored to Your Trading Interests
Find Stocks Tailored to Your Trading Interests
Benzinga Pro offers a real-time newsfeed as headlines break on earnings releases, analyst ratings, rumors, the biggest movers, and many more actionable alerts.

Compare Benzinga's Favorite Stock Brokers

Claim Exclusive Offers

Compare Benzinga's Favorite Cryptocurrency Brokers

Claim Exclusive Offers